Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc N.MMED.WA


Primary Symbol: MNMD Alternate Symbol(s):  N.MMED.WS | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > $30 up in one day coming
View:
Post by maysteeler23 on Feb 10, 2021 7:29pm

$30 up in one day coming

Mmmmmhhmmmm mmmmmhhhhmmmmmm. Get in before it's too late
Comment by horseraddish on Feb 10, 2021 8:00pm
You keep on repeating this..... How come? Would be nice
Comment by maysteeler23 on Feb 10, 2021 8:23pm
Shorts were warned with GME,  but they didn't learn.  1.5 million new short shares were added from dec 31 2020- jan 15 2021.  An increase of 66%. https://www.marketbeat.com/stocks/OTCMKTS/MMEDF/short-interest/ A total of about 3 million shares were added from dec 2020 -Jan 15.  Who knows how much it is now? You 2x the share price and you wipe about about 3 million ...more  
Comment by TeddyTenBags on Feb 11, 2021 10:25am
You're out to lunch pal. Stop spewing this garbage. There won't be a short squeeze on this stock any time soon. Current short volume is 946,200 shares, which is less than 1% of the total share count for the company. Stop trying to pull one over on inexperienced traders and pump the stock. For anyone on this board, let the science and R&D take this stock where it needs to go. Literally ...more  
Comment by horseraddish on Feb 11, 2021 11:36am
We need more people like you around here. Thanks
Comment by TeddyTenBags on Feb 11, 2021 8:58pm
Notice the no response? When you come with facts to prove them wrong, the pumpers always disappear. Don't let anyone tell you listing on the Nasdaq will take us to the moon either. Literally does nothing to get new drugs and therapeutics to market faster than the current timelines. Opens them up to new investors, but doesn't mean the demand will be there. Compass Pathways is on the ...more  
Comment by maysteeler23 on Feb 17, 2021 7:45pm
Nasdaq listing is coming!!! ;). Not what most think.  The army is building.  The storming of the beaches will be epic. Raise the asks to $30+.   Shorts are most exposed around $7-$8 range-  margin calls will go ballistic.    The trap is set for the shorts.  They have no idea what's coming!   Get in the way of the coming boom and you'll get ...more  
Comment by TeddyTenBags on Feb 18, 2021 12:17am
Get lost. There is no one shorting this stock. Less than 1%. Go pump and dump somewhere else idiot.
Comment by Unimaginatively on Apr 29, 2021 2:11pm
Easily. In one to two years 30 dollars should be imminent.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities